DK0817852T3 - Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein - Google Patents

Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein

Info

Publication number
DK0817852T3
DK0817852T3 DK96912467T DK96912467T DK0817852T3 DK 0817852 T3 DK0817852 T3 DK 0817852T3 DK 96912467 T DK96912467 T DK 96912467T DK 96912467 T DK96912467 T DK 96912467T DK 0817852 T3 DK0817852 T3 DK 0817852T3
Authority
DK
Denmark
Prior art keywords
protein
human papillomavirus
synthetic
hpv6
hybrid
Prior art date
Application number
DK96912467T
Other languages
Danish (da)
English (en)
Inventor
Kathrin U Jansen
Hugh A George
Kathryn J Hofmann
Joseph G Joyce
Michael P Neeper
E Dale Lehman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27022236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0817852(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0817852T3 publication Critical patent/DK0817852T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK96912467T 1995-03-30 1996-03-26 Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein DK0817852T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41357195A 1995-03-30 1995-03-30
US41357295A 1995-03-30 1995-03-30
PCT/US1996/004117 WO1996030520A2 (fr) 1995-03-30 1996-03-26 Adn de synthese hybride hpv6/11 l1 codant pour des proteines de papillomavirus humain de type 11 l1

Publications (1)

Publication Number Publication Date
DK0817852T3 true DK0817852T3 (da) 2003-11-24

Family

ID=27022236

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96912467T DK0817852T3 (da) 1995-03-30 1996-03-26 Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein

Country Status (21)

Country Link
US (1) US6159729A (fr)
EP (1) EP0817852B1 (fr)
JP (1) JP3918877B2 (fr)
KR (1) KR100441477B1 (fr)
CN (1) CN1154732C (fr)
AT (1) ATE247712T1 (fr)
AU (1) AU708111B2 (fr)
CZ (1) CZ291375B6 (fr)
DE (1) DE69629556T2 (fr)
DK (1) DK0817852T3 (fr)
EA (1) EA000969B1 (fr)
ES (1) ES2203691T3 (fr)
HU (1) HU228490B1 (fr)
IL (1) IL117591A0 (fr)
NO (1) NO320086B1 (fr)
NZ (1) NZ306663A (fr)
PL (1) PL183299B1 (fr)
PT (1) PT817852E (fr)
SK (1) SK283998B6 (fr)
WO (1) WO1996030520A2 (fr)
ZA (1) ZA962526B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL319294A1 (en) * 1994-09-22 1997-08-04 Merck & Co Inc Dna encoding the human papilloma virus of 6 a type
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
ES2216280T3 (es) * 1997-04-08 2004-10-16 MERCK & CO., INC. Formulaciones estabilizadas de papilomavirus humano.
SI1105466T1 (sl) * 1998-08-14 2006-08-31 Merck & Co Inc Postopek za ciscenje virusu podobnih delcev humanega papilomskega virusa
DE19840263C1 (de) 1998-09-03 2000-05-25 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US6380364B1 (en) 1998-11-23 2002-04-30 Loyola University Of Chicago Chimeric biotin-binding papillomavirus protein
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
SI1150712T1 (sl) 1999-02-05 2009-02-28 Merck & Co Inc Pripravek cepiva proti humanem papiloma virusu
US7001995B1 (en) * 1999-08-25 2006-02-21 Merck & Co., Inc. Synthetic human papillomavirus genes
SI1421200T1 (sl) * 2001-08-23 2007-04-30 Merck & Co Inc Poskusi PCR fluorescentnih multipleks HPV-jev z uporabo vec fluoroforov
EP1302550A1 (fr) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Procédé et détecteur pour la détection de virus de type de HPV
RU2005131016A (ru) * 2003-03-07 2006-06-10 Мерк энд Ко., Инк. (US) Вакцина вируса гриппа
AU2004224335B2 (en) 2003-03-24 2010-01-28 Merck Sharp & Dohme Llc Optimized expression of HPV 31 L1 in yeast
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US7527948B2 (en) * 2003-09-25 2009-05-05 Third Wave Technologies, Inc. Detection of HPV
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
MY139500A (en) * 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
TWI349036B (en) * 2004-03-24 2011-09-21 Merck Sharp & Dohme Optimized expression of hpv 52 l1 in yeast
EP1819835B1 (fr) 2004-12-08 2010-08-04 Gen-Probe Incorporated Detection d'acides nucleiques de types multiples de papillomavirus humains
ES2524050T3 (es) * 2004-12-10 2014-12-03 Genera Biosystems Limited Detección del virus del papiloma humano (VPH) usando sondas de ácidos nucleicos, microperlas y clasificadores celulares activados por fluorescencia (FACS)
WO2007057669A2 (fr) * 2005-11-15 2007-05-24 Genoid Kft. Procede
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
CN101200696B (zh) * 2007-11-14 2011-07-20 山东大学 人乳头瘤病毒的酵母增殖模型及建立方法与应用
KR20090073987A (ko) * 2007-12-31 2009-07-03 정운원 인간유두종바이러스 유전자형 검사를 위한 프라이머, 프로브 및 이를 포함하는 ｄｎａ칩, 이의 검사 방법 및 검사 키트
WO2011149897A1 (fr) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Analyse de capture hybride à résultats rapides et sondes associées tronquées de manière stratégique
WO2012065034A1 (fr) 2010-11-12 2012-05-18 Merck Sharp & Dohme Corp. Vaccins à base de conjugués de peptide énolase, contre staphylococcus aureus
CN103717741B (zh) * 2011-06-15 2016-04-13 中央大学校产学协力团 用于提高人乳头瘤病毒l1蛋白产量的方法
BR112018011331A2 (pt) 2015-12-04 2019-04-30 Xiamen Innovax Biotech Co., Ltd. mutante de proteìna l1 de papillomavirus humano tipo 11
JP7290258B2 (ja) 2018-09-26 2023-06-13 厦▲門▼大学 ヒトパピローマウイルス５１型のｌ１タンパク質の変異型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476389B1 (en) * 1991-07-19 2009-01-13 The University Of Queensland Papillomavirus vaccines
DE122007000014I1 (de) * 1993-03-09 2007-05-24 Univ Rochester Herstellung von menschlichem Papillomavirus Hüllprotein und virus-ähnlichen Teilchen

Also Published As

Publication number Publication date
WO1996030520A2 (fr) 1996-10-03
SK129397A3 (en) 1998-05-06
KR19980703391A (ko) 1998-10-15
ES2203691T3 (es) 2004-04-16
EP0817852B1 (fr) 2003-08-20
IL117591A0 (en) 1996-07-23
JP3918877B2 (ja) 2007-05-23
HUP9801608A3 (en) 1999-04-28
CN1154732C (zh) 2004-06-23
EA000969B1 (ru) 2000-08-28
HUP9801608A2 (hu) 1998-10-28
AU708111B2 (en) 1999-07-29
HU228490B1 (en) 2013-03-28
DE69629556D1 (de) 2003-09-25
PT817852E (pt) 2003-12-31
EP0817852A2 (fr) 1998-01-14
NO974514L (no) 1997-11-27
US6159729A (en) 2000-12-12
ATE247712T1 (de) 2003-09-15
ZA962526B (en) 1996-09-04
DE69629556T2 (de) 2004-06-17
PL183299B1 (pl) 2002-06-28
CZ309197A3 (cs) 1998-02-18
JPH11503313A (ja) 1999-03-26
CZ291375B6 (cs) 2003-02-12
WO1996030520A3 (fr) 1996-11-07
NO974514D0 (no) 1997-09-29
EA199700281A1 (ru) 1998-04-30
SK283998B6 (sk) 2004-07-07
CN1185810A (zh) 1998-06-24
NO320086B1 (no) 2005-10-24
PL322588A1 (en) 1998-02-02
AU5527796A (en) 1996-10-16
NZ306663A (en) 1999-10-28
KR100441477B1 (ko) 2004-10-06

Similar Documents

Publication Publication Date Title
DK0817852T3 (da) Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein
BG100974A (en) Vaccines against papillomavirus
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
DE69519856D1 (de) Expression von albumin in hefe
DE69818450D1 (de) Im wesentlichen reines zonulin als physiologischer modulator von "tight junctions" bei säugern
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
BG101338A (en) Dna encoding human papillomavirus type 6a
IL122606A (en) (S)-hydroxa-nitrile-lyase
IT1277391B1 (it) Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita
MX9707457A (es) Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
ATE267209T1 (de) Reinigung von carboxaldehyd
SE9501512D0 (sv) Synthetic peptide-defined eptopes useful for vaccination against papillomavirus
ATE198315T1 (de) Dimethyl-substituierte cyclohexandienderivate
ATE328088T1 (de) Transketolase-verwandtes protein
SE9704834D0 (sv) New process
DK0858465T3 (da) Protein med antitumorvirkning.
NO982151D0 (no) Hemoregulatoriske forbindelser
BR9705217C2 (pt) Registro de datas em seis digitos até 31/c/z99.